May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Prokineticin 1 induces choroidal angiogenesis but not retinal angiogenesis; a possible model for the pathogenesis of age–related macular degeneration
Author Affiliations & Notes
  • N. Tanaka
    Lab Genetics, Salk Institute, La Jolla, CA
  • M. Ikawa
    Lab Genetics, Salk Institute, La Jolla, CA
  • K. Bessho
    Shiley Eye Center, University of California San Diego, La Jolla, CA
  • W.R. Freeman
    Shiley Eye Center, University of California San Diego, La Jolla, CA
  • I.M. Verma
    Lab Genetics, Salk Institute, La Jolla, CA
  • Footnotes
    Commercial Relationships  N. Tanaka, None; M. Ikawa, None; K. Bessho, None; W.R. Freeman, None; I.M. Verma, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1820. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. Tanaka, M. Ikawa, K. Bessho, W.R. Freeman, I.M. Verma; Prokineticin 1 induces choroidal angiogenesis but not retinal angiogenesis; a possible model for the pathogenesis of age–related macular degeneration . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1820.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: The pathogenesis of age–related macular degeneration (AMD) is not fully understood. Recently prokineticin 1 (hPK1) was identified as a mitogen specific for the fenestrated endothelium. We hypothesized that hPK1 could induce choroidal neovascularization (CNV) without retinal angiogenesis, because the endothelium of choriocapillaris, but not retinal endothelium, has fenestrated phenotype. To verify the hypothesis we performed both in vitro and in vivo experiment. Methods: We performed RT–PCR to detect mRNA of hPKs and their receptors, hPKRs in both retinal pigment epithelial cell line (RPE) and retinochoroidal endothelial cell line (RCEC). Cell viability and signal transduction induced by hPKs was examined by MTT assay and Western blot analysis respectively. To see the effect of hPK1 in the eye, transgenic mouse was generated and their phenotype was evaluated by fluorescein angiography and histology. The level of hPK1 in vitreous samples from AMD patients was assessed by Western blot analysis. Results: First, we detected transcripts of hPK1 and its homologue hPK2, and their receptors, hPKR1 and hPKR2, in both RPE and RCEC. Second, we found that the viability of RCEC expressing hPK1 and hPK2 transduced by lentiviral vectors was increased possibly through the activation of Akt and/or ERK kinases. Surprisingly we also found that the viability of RPE cells expressing hPK1 was decreased via inhibition of ERK activation. Third, we could observe choroidal angiogenesis, but not retinal angiogenesis, in the transgenic mice that overexpressed hPK1 in retina. Finally, hPK1 levels in vitreous samples from AMD patients and proliferative diabetic retinopathy patients were elevated compared to those from control patients. Conclusions: According to these results, we offer a novel concept for the pathogenesis of AMD that increased hPK1 might damage RPE cells and induce CNV in the diseased eyes.

Keywords: age–related macular degeneration • growth factors/growth factor receptors • transgenics/knock–outs 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×